Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer

Detalles Bibliográficos
Autores principales: Fiore, F Di, Charbonnier, F, Lefebure, B, Laurent, M, Pessot, F Le, Michel, P, Frebourg, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527802/
https://www.ncbi.nlm.nih.gov/pubmed/18594536
http://dx.doi.org/10.1038/sj.bjc.6604451
_version_ 1782158839996481536
author Fiore, F Di
Charbonnier, F
Lefebure, B
Laurent, M
Pessot, F Le
Michel, P
Frebourg, T
author_facet Fiore, F Di
Charbonnier, F
Lefebure, B
Laurent, M
Pessot, F Le
Michel, P
Frebourg, T
author_sort Fiore, F Di
collection PubMed
description
format Text
id pubmed-2527802
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-25278022009-09-11 Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer Fiore, F Di Charbonnier, F Lefebure, B Laurent, M Pessot, F Le Michel, P Frebourg, T Br J Cancer Letter to the Editor Nature Publishing Group 2008-08-05 2008-07-01 /pmc/articles/PMC2527802/ /pubmed/18594536 http://dx.doi.org/10.1038/sj.bjc.6604451 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Fiore, F Di
Charbonnier, F
Lefebure, B
Laurent, M
Pessot, F Le
Michel, P
Frebourg, T
Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
title Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
title_full Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
title_fullStr Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
title_full_unstemmed Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
title_short Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
title_sort clinical interest of kras mutation detection in blood for anti-egfr therapies in metastatic colorectal cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527802/
https://www.ncbi.nlm.nih.gov/pubmed/18594536
http://dx.doi.org/10.1038/sj.bjc.6604451
work_keys_str_mv AT fiorefdi clinicalinterestofkrasmutationdetectioninbloodforantiegfrtherapiesinmetastaticcolorectalcancer
AT charbonnierf clinicalinterestofkrasmutationdetectioninbloodforantiegfrtherapiesinmetastaticcolorectalcancer
AT lefebureb clinicalinterestofkrasmutationdetectioninbloodforantiegfrtherapiesinmetastaticcolorectalcancer
AT laurentm clinicalinterestofkrasmutationdetectioninbloodforantiegfrtherapiesinmetastaticcolorectalcancer
AT pessotfle clinicalinterestofkrasmutationdetectioninbloodforantiegfrtherapiesinmetastaticcolorectalcancer
AT michelp clinicalinterestofkrasmutationdetectioninbloodforantiegfrtherapiesinmetastaticcolorectalcancer
AT frebourgt clinicalinterestofkrasmutationdetectioninbloodforantiegfrtherapiesinmetastaticcolorectalcancer

Ejemplares similares